Company intelligence / Profile preview

Factorial Biotechnologies

San Carlos, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Factorial Biotechnologies has developed Mosaic™, a beadless, single-cell NGS platform enabling simultaneous single-cell DNA, RNA, and multi-omic library preparation within intact cells. The technology allows rapid, cost-effective, extraction-free workflows for high-resolution cellular analysis. Mosaic has recently entered early access collaborations with leading academic labs; no clinical trial results have been disclosed[4][5][8].

Therapeutic areas: ImmunologyRare DiseasesHematologyOtherOncology
Modalities: DevicePlatform technology (in-cell library preparation chemistry)Next-generation sequencing (NGS) kit
Industry: Non-Drug Biotech

Partnerships

Ginkgo Bioworks (development of isothermal DNA polymerase for NGS kit)[3]

Beyond the preview

Go deeper on Factorial Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Factorial Biotechnologies.

Explore the full profile